SARS-CoV-2 evolution during treatment of chronic infection অনুযায়ী Kemp, SA, Collier, DA, Datir, RP, Ferreira, IATM, Gayed, S, Jahun, A, Hosmillo, M, Rees-Spear, C, Mlcochova, P, Lumb, IU, Roberts, DJ, Chandra, A, Temperton, N, Sharrocks, K, Blane, E, Modis, Y, Leigh, KE, Briggs, JAG, van Gils, MJ, Smith, KGC, Bradley, JR, Smith, C, Doffinger, R, Ceron-Gutierrez, L, Barcenas-Morales, G, Pollock, DD, Goldstein, RA, Smielewska, A, Skittrall, JP, Gouliouris, T, Goodfellow, IG, Gkrania-Klotsas, E, Illingworth, CJR, McCoy, LE, Gupta, RK

Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant অনুযায়ী Mlcochova, P, Collier, D, Ritchie, A, Assennato, SM, Hosmillo, M, Goel, N, Meng, B, Chatterjee, K, Mendoza, V, Temperton, N, Kiss, L, James, LC, Ciazynska, KA, Xiong, X, Briggs, JAG, Nathan, JA, Mescia, F, Bergamaschi, L, Zhang, H, Barmpounakis, P, Demeris, N, Skells, R, Lyons, PA, Bradley, J, Baker, S, Allain, JP, Smith, KGC, Bousfield, R, Wilson, M, Sparkes, D, Amoroso, G, Gkrania-Klotsas, E, Hardwick, S, Boyle, A, Goodfellow, I, Gupta, RK, Baker, S, Dougan, G, Gupta, R, Lehner, PJ, Lyons, P, Matheson, NJ, Toshner, M, Weekes, MP, Brown, N, Curran, M, Palmar, S, Enoch, D, Chapman, D, Shaw, A